Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naive New Zealand cohort. Lavender B, Hooker C, Frampton C, Williams M, et al. Vaccine 2023 Jul 27:S0264-410X(23)00882-4. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Lavender B, Hooker C, Frampton C, Williams M, et al. Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naive New Zealand cohort. Vaccine 2023 Jul 27:S0264-410X(23)00882-4. doi: 10.1016/j.vaccine.2023.
PMID: 37516574